scholarly journals Efficient Protein Transduction Method Using Cationic Peptides and Lipids

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Kei Yamaguchi ◽  
Mari Inoue ◽  
Naoki Goshima
Keyword(s):  
Protein Delivery ◽  
Cationic Lipid ◽  
Living Cells ◽  
Protein Transduction ◽  
Cationic Peptides ◽  
Proton Sponge ◽  
Protein Transduction Domains ◽  
Cargo Proteins ◽  
Endosomal Vesicles ◽  
Novel Protein

Cationic peptides termed protein transduction domains (PTDs) have been shown to cross biological membranes efficiently. However, proteins transduced by PTDs become entrapped within the endosomal vesicles and are not delivered into organelles. We have developed a novel protein delivery system to enhance the proton sponge effect, which results in rupture of the endosomes, by using a mixture of Wr-T transporter peptide and a commercially available cationic lipid reagent. This peptide and cationic lipid reagent mixture efficiently delivers a variety of cargo proteins into living cells by releasing them from the endosomes.

scholarly journals Antibody Mediated Transduction of Therapeutic Proteins into Living Cells

2005 ◽  
Vol 5 ◽  
pp. 782-788 ◽  
Author(s):  
James E. Hansen ◽  
Richard H. Weisbart ◽  
Robert N. Nishimura
Keyword(s):  
Therapeutic Proteins ◽  
Disease Process ◽  
Antibody Fragment ◽  
Living Cells ◽  
Cell Penetrating Peptides ◽  
Biologically Active ◽  
Protein Transduction ◽  
Protein Therapy ◽  
Single Chain ◽  
Protein Transduction Domains

Protein therapy refers to the direct delivery of therapeutic proteins to cells and tissues with the goal of ameliorating or modifying a disease process. Current techniques for delivering proteins across cell membranes include taking advantage of receptor-mediated endocytosis or using protein transduction domains that penetrate directly into cells. The most commonly used protein transduction domains are small cell-penetrating peptides derived from such proteins as the HIV-1 Tat protein. A novel protein transduction domain developed as the single chain fragment (Fv) of a murine anti-DNA autoantibody, mAb 3E10, has recently been developed and used to deliver biologically active proteins to living cellsin vitro. This review will provide a brief overview of the development of the Fv fragment and provide a summary of recent studies using Fv to deliver therapeutic peptides and proteins (such as a C-terminal p53 peptide, C-terminal p53 antibody fragment, full-length p53, and micro-dystrophin) to cells.

scholarly journals Creation of Novel Protein Transduction Domain (PTD) Mutants by a Phage Display-Based High-Throughput Screening System

2006 ◽  
Vol 29 (8) ◽  
pp. 1570-1574 ◽  
Author(s):  
Yohei Mukai ◽  
Toshiki Sugita ◽  
Tomoko Yamato ◽  
Natsue Yamanada ◽  
Hiroko Shibata ◽  
...  
Keyword(s):  
Phage Display ◽  
High Throughput ◽  
High Throughput Screening ◽  
Protein Transduction ◽  
Protein Transduction Domain ◽  
Screening System ◽  
Novel Protein

scholarly journals Protein Transduction Domains Fused to Virus Receptors Improve Cellular Virus Uptake and Enhance Oncolysis by Tumor-Specific Replicating Vectors

2004 ◽  
Vol 78 (24) ◽  
pp. 13743-13754 ◽  
Author(s):  
Florian Kühnel ◽  
Bernd Schulte ◽  
Thomas Wirth ◽  
Norman Woller ◽  
Sonja Schäfers ◽  
...  
Keyword(s):  
Viral Vectors ◽  
Protein Transduction ◽  
Virus Binding ◽  
Adenoviral Infection ◽  
Protein Transduction Domains ◽  
Oncolytic Therapy ◽  
Uptake Rates ◽  
Immunodeficiency Virus ◽  
Transactivator Of Transcription ◽  
Adenovirus Receptor

ABSTRACT Expression of cellular receptors determines viral tropism and limits gene delivery by viral vectors. Protein transduction domains (PTDs) have been shown to deliver proteins, antisense oligonucleotides, liposomes, or plasmid DNA into cells. In our study, we investigated the role of several PTD motifs in adenoviral infection. When physiologically expressed, a PTD from human immunodeficiency virus transactivator of transcription (Tat) did not improve adenoviral infection. We therefore fused PTDs to the ectodomain of the coxsackievirus-adenovirus receptor (CARex) to attach PTDs to adenoviral fiber knobs. CARex-Tat and CARex-VP22 allowed efficient adenoviral infection in nonpermissive cells and significantly improved viral uptake rates in permissive cells. Dose-dependent competition of CARex-PTD-mediated infection using CARex and inhibition experiments with heparin showed that binding of CARex-PTD to both adenoviral fiber and cellular glycosaminoglycans is essential for the improvement of infection. CARex-PTD-treated adenoviruses retained their properties after density gradient ultracentrifugation, indicating stable binding of CARex-PTD to adenoviral particles. Consequently, the mechanism of CARex-PTD-mediated infection involves coating of the viral fiber knobs by CARex-PTD, rather than placement of CARex domains on cell surfaces. Expression of CARex-PTDs led to enhanced lysis of permissive and nonpermissive tumor cells by replicating adenoviruses, indicating that CARex-PTDs are valuable tools to improve the efficacy of oncolytic therapy. Together, our study shows that CARex-PTDs facilitate gene transfer in nonpermissive cells and improve viral uptake at reduced titers and infection times. The data suggest that PTDs fused to virus binding receptors may be a valuable tool to overcome natural tropism of vectors and could be of great interest for gene therapeutic approaches.

scholarly journals Enhanced skin penetration of P20 phosphopeptide using protein transduction domains

2008 ◽  
Vol 68 (2) ◽  
pp. 441-445 ◽  
Author(s):  
Luciana B. Lopes ◽  
Elizabeth Furnish ◽  
Padmini Komalavilas ◽  
Brandon L. Seal ◽  
Alyssa Panitch ◽  
...  
Keyword(s):  
Skin Penetration ◽  
Protein Transduction ◽  
Protein Transduction Domains

scholarly journals GFP-complementation assay to detect functional CPP and protein delivery into living cells

2015 ◽  
Vol 5 (1) ◽  
Author(s):  
Nadia Milech ◽  
Brooke AC Longville ◽  
Paula T Cunningham ◽  
Marie N Scobie ◽  
Heique M Bogdawa ◽  
...  
Keyword(s):  
Protein Delivery ◽  
Living Cells ◽  
Complementation Assay

scholarly journals A boronic acid–rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing

2019 ◽  
Vol 5 (6) ◽  
pp. eaaw8922 ◽  
Author(s):  
Chongyi Liu ◽  
Tao Wan ◽  
Hui Wang ◽  
Song Zhang ◽  
Yuan Ping ◽  
...  
Keyword(s):  
Boronic Acid ◽  
Protein Delivery ◽  
High Efficiency ◽  
Intracellular Delivery ◽  
Cytosolic Protein ◽  
Native Proteins ◽  
Cytosolic Delivery ◽  
Cas9 Protein ◽  
Cargo Proteins ◽  
Positively Charged

Cytosolic protein delivery is of central importance for the development of protein-based biotechnologies and therapeutics; however, efficient intracellular delivery of native proteins remains a challenge. Here, we reported a boronic acid–rich dendrimer with unprecedented efficiency for cytosolic delivery of native proteins. The dendrimer could bind with both negatively and positively charged proteins and efficiently delivered 13 cargo proteins into the cytosol of living cells. All the delivered proteins kept their bioactivities after cytosolic delivery. The dendrimer ensures efficient intracellular delivery of Cas9 protein into various cell lines and showed high efficiency in CRISPR-Cas9 genome editing. The rationally designed boronic acid–rich dendrimer permits the development of an efficient platform with high generality for the delivery of native proteins.

Taking the Cell by Stealth or Storm? Protein Transduction Domains (PTDs) as Versatile Vectors for Delivery

2002 ◽  
Vol 21 (12) ◽  
pp. 879-894 ◽  
Author(s):  
Marie A. Bogoyevitch ◽  
Tulene S. Kendrick ◽  
Dominic C.H. Ng ◽  
Renae K. Barr
Keyword(s):  
Protein Transduction ◽  
Protein Transduction Domains
Sign in / Sign up

Export Citation Format

Share Document